Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.37%)
At close: Sep 4, 2026 · 4:00 PM EDT

Compugen (CGEN) Cash & Current Investments (2009 - 2026)

Compugen (CGEN) posted quarterly Cash & Current Investments of $91.8 million for Q1 2026, up 29.13% year-over-year from $71.1 million in Q1 2025, and down 32.71% on a QoQ basis from $136.4 million in Q4 2025.

Analysis

Compugen (CGEN) Cash & Current Investments (2009 - 2026) Analysis & Trends

Compugen has reported Cash & Current Investments for 18 years, with the latest figure at $91.8 million in Q1 2026.

  • Cash & Current Investments for Q1 2026 came in at $91.8 million, up 29.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $91.8 million (up 29.13% YoY), and the FY2025 annual result was $136.4 million, up 71.25% from the prior year.
  • Cash & Current Investments fell to $91.8 million in Q1 2026, from $136.4 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $136.4 million in Q4 2025 and troughed at $38.9 million in Q4 2023.
  • A 5-year average of $77.0 million and a median of $74.3 million in 2023 frame the typical range for Cash & Current Investments.
  • The widest annual swing landed in 2023, when Cash & Current Investments plunged 53.28%; it then surged 104.47% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $83.3 million in 2022, then plunged by 53.28% to $38.9 million in 2023, then surged by 104.47% to $79.6 million in 2024, then soared by 71.25% to $136.4 million in 2025, then sank by 32.71% to $91.8 million in 2026.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $91.8 million in Q1 2026, $136.4 million in Q4 2025, and $59.4 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.14 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 3.31 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 836.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.16 Bn
10 Compugen 242.44 Mn 156.82 Mn -92,000.00 85.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 85.62 Mn
Mar 31, 2026 91.75 Mn
Dec 31, 2025 136.36 Mn
Sep 30, 2025 59.36 Mn
Jun 30, 2025 65.00 Mn
Mar 31, 2025 71.06 Mn
Dec 31, 2024 79.63 Mn
Sep 30, 2024 79.57 Mn
Jun 30, 2024 59.32 Mn
Mar 31, 2024 69.05 Mn
Dec 31, 2023 38.94 Mn
Sep 30, 2023 47.78 Mn
Jun 30, 2023 61.98 Mn
Mar 31, 2023 74.32 Mn
Dec 31, 2022 83.35 Mn
Sep 30, 2022 88.21 Mn
Jun 30, 2022 97.29 Mn
Mar 31, 2022 106.82 Mn
Dec 31, 2021 117.05 Mn
Sep 30, 2021 102.25 Mn